HOME >> MEDICINE >> NEWS
Delayed-release stimulant used to treat ADHD may be less subject to abuse

A team led by Massachusetts General Hospital (MGH) researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder (ADHD) may be less likely to be abused than other stimulant drugs. Study participants taking therapeutic oral doses of Concerta, a once-daily form of the drug methylphenidate, did not report perceiving and enjoying the drug's subjective effects, features that are associated with a medication's potential for abuse. The report appears in the March 2006 issue of The American Journal of Psychiatry.

"We know that drugs that cause euphoria are potentially abusable, and euphoria requires rapid delivery to the brain. Using sophisticated PET scan imaging, we were able to examine the rate of delivery of both rapid- and delayed-release formulations of methylphenidate and correlate those results with how the drugs felt to study volunteers," says Thomas Spencer, MD, of the MGH Pediatric Psychopharmacology Unit, the paper's lead author. "The ability to show that rate of brain delivery may determine abuse potential is important to our understanding of the safety of different formulations."

Methylphenidate and other stimulant drugs used to treat ADHD act by blocking the dopamine transporter, a molecule on brain cells that takes up the neurotransmitter dopamine, raising its level in the brain. Studies have shown that the brains of ADHD patients have abnormal regulation of dopamine, which plays a key role in the control of movement, behavior and attention. While stimulants are effective for controlling ADHD symptoms, the drugs are also subject to abuse, so the current study was designed to compare the abuse potential of two formulations of methylphenidate.

The researchers compared a traditional, quick-release form of the drug with Concerta, a formulation that is released over 12 hours to produce a gradual increase in blood levels. With Concerta, the drug passes slowly through a hole in capsul
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
1-Mar-2006


Page: 1 2

Related medicine news :

1. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
2. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
3. Study examines risk for misuse of ADHD stimulant medications
4. Spot on treatment for acne
5. Using coxibs and NSAIDs to treat osteoarthritis
6. New treatment boosts muscle function in myasthenia gravis
7. New treatment effective in counteracting cocaine-induced symptoms
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Despite claims, not all probiotics can treat diarrhea say experts
10. Preventive treatments in elderly people needs rethinking
11. Osteoporosis screening and treatment may be cost-effective for selected older men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2018)... ... ... SignatureCare Emergency Center is looking to award their 2018 Fall Scholarship. The $1000 ... your applications in now as the deadline is approaching fast. (July 31) , SignatureCare ... student at Texas Southern University. Wu was inspired to go into the medical field ...
(Date:8/31/2018)... ... 31, 2018 , ... MedMark Treatment Centers Kentwood, a BayMark ... from 1:00-3:00 pm. MedMark invites the community to explore the world ... meet our staff and learn more about medication-assisted treatment services. MedMark Kentwood can ...
(Date:8/31/2018)... (PRWEB) , ... August 31, 2018 , ... Nitro Circus ... SeaLegs at the Beach – an action sports gathering to celebrate the life of ... The event raised money for Erik’s wife, Annika and their two small children, Oskar ...
(Date:8/31/2018)... ... 2018 , ... ZPower, the world’s only developer of rechargeable, ... Information Officer. Arneja previously served as Director of Information Systems and in his ... scale, and innovate the business. , Prior to joining ZPower, Arneja gained ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... socialize or communicate with others. Physically, it is not possible to identify people ... problems may be challenged. People with autism may need assistance in developing skills, ...
Breaking Medicine News(10 mins):
(Date:9/1/2018)... ... September 01, 2018 , ... Dr. Payam Bostani is now offering Periodontal ... he has been offering patients for twenty years at his Burbank offices. “My ... are likely to need under a single roof. Periodontics is a crucial specialty because ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... Government to acquire, such as medications for cancer, mental health and required blood ... used to treat Respiratory Distress Syndroms (RDS) in premature babies and can be ...
(Date:8/31/2018)... ... 31, 2018 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... Tabernacles topics and events. He says polls show the world is begging for answers ... , Yisrayl says The House of Yahweh has been asked to teach solutions ...
Breaking Medicine Technology:
Cached News: